Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone

Norio Maeda, Mamoru Watanabe, Susumu Okamoto, Takanori Kanai, Taketo Yamada, Jun Ichi Hata, Nobumichi Hozumi, Asao Katsume, Hideko Nuriya, Jasbir Sandhu, Hiromasa Ishii, Michinori Kohara, Toshifumi Hibi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background/Aims: Recent advances in molecular cloning of hepatitis C virus (HCV) have enabled us to apply some available HCV molecular clones to experimental studies. However, these investigations have been restricted to chimpanzee models or 'isolated hepatocytes' from tree shrews. In this study, we engrafted 'human liver tissue' into immunodeficient mice and investigated HCV infection using an infectious molecular clone. Methods: Human liver tissues from normal (non-HCV-infected) liver were transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We then inoculated the mice with sera from HCV-infected patients or an infectious HCV molecular clone. HCV RNA was assessed using nested reverse-transcription polymerase chain reaction (PCR), real-time detection PCR and in situ PCR. Results: Without any growth support, normal human liver tissues survived in NOD/SCID mice while maintaining the original viable hepatic architecture. HCV RNA was detected in the mice serum until the fourth week after the inoculation. In situ PCR and immunohistochemistry clearly demonstrated positive signals for HCV in the cytoplasm of infected hepatocytes, while the engrafted human liver tissues showed no apparent morphological changes indicative of infection. Conclusion: Engraftment of human liver tissues into NOD/SCID mice and infection with HCV molecular clones could offer a reverse genetic strategy for HCV infection.

Original languageEnglish
Pages (from-to)259-267
Number of pages9
JournalLiver International
Volume24
Issue number3
Publication statusPublished - 2004 Jun
Externally publishedYes

Fingerprint

Virus Diseases
Hepacivirus
Clone Cells
Liver
Severe Combined Immunodeficiency
Polymerase Chain Reaction
Hepatocytes
Hepatovirus
Tupaiidae
RNA
Reverse Genetics
Pan troglodytes
Molecular Cloning
Infection
Serum
Reverse Transcription
Real-Time Polymerase Chain Reaction
Cytoplasm
Immunohistochemistry
Viruses

Keywords

  • Hepatitis C virus
  • Human liver tissue
  • In situ PCR
  • Infectious molecular clone
  • NOD/SCID mouse

ASJC Scopus subject areas

  • Hepatology

Cite this

Maeda, N., Watanabe, M., Okamoto, S., Kanai, T., Yamada, T., Hata, J. I., ... Hibi, T. (2004). Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone. Liver International, 24(3), 259-267.

Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone. / Maeda, Norio; Watanabe, Mamoru; Okamoto, Susumu; Kanai, Takanori; Yamada, Taketo; Hata, Jun Ichi; Hozumi, Nobumichi; Katsume, Asao; Nuriya, Hideko; Sandhu, Jasbir; Ishii, Hiromasa; Kohara, Michinori; Hibi, Toshifumi.

In: Liver International, Vol. 24, No. 3, 06.2004, p. 259-267.

Research output: Contribution to journalArticle

Maeda, N, Watanabe, M, Okamoto, S, Kanai, T, Yamada, T, Hata, JI, Hozumi, N, Katsume, A, Nuriya, H, Sandhu, J, Ishii, H, Kohara, M & Hibi, T 2004, 'Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone', Liver International, vol. 24, no. 3, pp. 259-267.
Maeda, Norio ; Watanabe, Mamoru ; Okamoto, Susumu ; Kanai, Takanori ; Yamada, Taketo ; Hata, Jun Ichi ; Hozumi, Nobumichi ; Katsume, Asao ; Nuriya, Hideko ; Sandhu, Jasbir ; Ishii, Hiromasa ; Kohara, Michinori ; Hibi, Toshifumi. / Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone. In: Liver International. 2004 ; Vol. 24, No. 3. pp. 259-267.
@article{f6c26c22f9f6487cb653c5cbe8c726ae,
title = "Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone",
abstract = "Background/Aims: Recent advances in molecular cloning of hepatitis C virus (HCV) have enabled us to apply some available HCV molecular clones to experimental studies. However, these investigations have been restricted to chimpanzee models or 'isolated hepatocytes' from tree shrews. In this study, we engrafted 'human liver tissue' into immunodeficient mice and investigated HCV infection using an infectious molecular clone. Methods: Human liver tissues from normal (non-HCV-infected) liver were transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We then inoculated the mice with sera from HCV-infected patients or an infectious HCV molecular clone. HCV RNA was assessed using nested reverse-transcription polymerase chain reaction (PCR), real-time detection PCR and in situ PCR. Results: Without any growth support, normal human liver tissues survived in NOD/SCID mice while maintaining the original viable hepatic architecture. HCV RNA was detected in the mice serum until the fourth week after the inoculation. In situ PCR and immunohistochemistry clearly demonstrated positive signals for HCV in the cytoplasm of infected hepatocytes, while the engrafted human liver tissues showed no apparent morphological changes indicative of infection. Conclusion: Engraftment of human liver tissues into NOD/SCID mice and infection with HCV molecular clones could offer a reverse genetic strategy for HCV infection.",
keywords = "Hepatitis C virus, Human liver tissue, In situ PCR, Infectious molecular clone, NOD/SCID mouse",
author = "Norio Maeda and Mamoru Watanabe and Susumu Okamoto and Takanori Kanai and Taketo Yamada and Hata, {Jun Ichi} and Nobumichi Hozumi and Asao Katsume and Hideko Nuriya and Jasbir Sandhu and Hiromasa Ishii and Michinori Kohara and Toshifumi Hibi",
year = "2004",
month = "6",
language = "English",
volume = "24",
pages = "259--267",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone

AU - Maeda, Norio

AU - Watanabe, Mamoru

AU - Okamoto, Susumu

AU - Kanai, Takanori

AU - Yamada, Taketo

AU - Hata, Jun Ichi

AU - Hozumi, Nobumichi

AU - Katsume, Asao

AU - Nuriya, Hideko

AU - Sandhu, Jasbir

AU - Ishii, Hiromasa

AU - Kohara, Michinori

AU - Hibi, Toshifumi

PY - 2004/6

Y1 - 2004/6

N2 - Background/Aims: Recent advances in molecular cloning of hepatitis C virus (HCV) have enabled us to apply some available HCV molecular clones to experimental studies. However, these investigations have been restricted to chimpanzee models or 'isolated hepatocytes' from tree shrews. In this study, we engrafted 'human liver tissue' into immunodeficient mice and investigated HCV infection using an infectious molecular clone. Methods: Human liver tissues from normal (non-HCV-infected) liver were transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We then inoculated the mice with sera from HCV-infected patients or an infectious HCV molecular clone. HCV RNA was assessed using nested reverse-transcription polymerase chain reaction (PCR), real-time detection PCR and in situ PCR. Results: Without any growth support, normal human liver tissues survived in NOD/SCID mice while maintaining the original viable hepatic architecture. HCV RNA was detected in the mice serum until the fourth week after the inoculation. In situ PCR and immunohistochemistry clearly demonstrated positive signals for HCV in the cytoplasm of infected hepatocytes, while the engrafted human liver tissues showed no apparent morphological changes indicative of infection. Conclusion: Engraftment of human liver tissues into NOD/SCID mice and infection with HCV molecular clones could offer a reverse genetic strategy for HCV infection.

AB - Background/Aims: Recent advances in molecular cloning of hepatitis C virus (HCV) have enabled us to apply some available HCV molecular clones to experimental studies. However, these investigations have been restricted to chimpanzee models or 'isolated hepatocytes' from tree shrews. In this study, we engrafted 'human liver tissue' into immunodeficient mice and investigated HCV infection using an infectious molecular clone. Methods: Human liver tissues from normal (non-HCV-infected) liver were transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We then inoculated the mice with sera from HCV-infected patients or an infectious HCV molecular clone. HCV RNA was assessed using nested reverse-transcription polymerase chain reaction (PCR), real-time detection PCR and in situ PCR. Results: Without any growth support, normal human liver tissues survived in NOD/SCID mice while maintaining the original viable hepatic architecture. HCV RNA was detected in the mice serum until the fourth week after the inoculation. In situ PCR and immunohistochemistry clearly demonstrated positive signals for HCV in the cytoplasm of infected hepatocytes, while the engrafted human liver tissues showed no apparent morphological changes indicative of infection. Conclusion: Engraftment of human liver tissues into NOD/SCID mice and infection with HCV molecular clones could offer a reverse genetic strategy for HCV infection.

KW - Hepatitis C virus

KW - Human liver tissue

KW - In situ PCR

KW - Infectious molecular clone

KW - NOD/SCID mouse

UR - http://www.scopus.com/inward/record.url?scp=3142746873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142746873&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 259

EP - 267

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 3

ER -